FDA label
What is teriparatide used for?
The FDA-approved uses of teriparatide, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Teriparatide injection is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, Teriparatide injection reduces the risk of vertebral ...”
Run it in Rivvi
Which 2027 plans near you dropped or restricted teriparatide?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Teriparatide, injection
Indications and Usage, quoted from the label by BluePoint Laboratories (ANDA213641). Cross-references to other label sections are left out.
Teriparatide injection is indicated:
- For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, Teriparatide injection reduces the risk of vertebral and nonvertebral fractures.
- To increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.
- For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.
Source: DailyMed label, set id 9d3f65e2-e8f0-4d33-b79e-989013dd3ca3, version 1, effective March 12, 2026. NDC 68001-693, one of 2 listings for this product.
Questions
What is teriparatide used for?
The FDA label says: “Teriparatide injection is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, Teriparatide injection reduces the risk of vertebral ...”
What drug class is teriparatide?
FDA lists teriparatide in the Parathyroid Hormone Analog established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.
More on Teriparatide
- Is Teriparatide a controlled substance?Federal schedule
- Generic for BonsityFDA Orange Book
- Generic for ForteoFDA Orange Book
- What is Forteo used for?FDA label uses
- Is Forteo a controlled substance?Federal schedule
- Parathyroid Hormone Analogs listFDA drug class
- Teriparatide Medicare Part D coverageBy plan and state
- NDC 0002-8400Teriparatide NDC record
- NDC 0002-9678Teriparatide NDC record
- NDC 47781-652Teriparatide NDC record